Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Oncolytics Biotech product
View:
Post by Lesalpes29 on Nov 29, 2022 9:08am

Oncolytics Biotech product

Can be used positively in many cancers indications in combination with orher products offered by a couple of BP. It's enough to see many of them interested to buy Onc, oncy out. Of course they could wait but if they want a good buyout price it's probably now. I really think that all members of management team are ready for an offer and move on. GL
Comment by Tarbaby on Nov 29, 2022 10:05am
Yes this company would be a great target for many bigger medical entities. Watch the share price double or tripple when that happens....long and strong on ONC
Comment by fox7mf on Nov 29, 2022 10:08am
From your mouth to the BOD's ears. You're right about the fact that BP shouldn't sit on their hands, and the more indications that are proven to benefit from Pela, the more the acquisition price escalates. I'm of the opinion that PFE, having access to real-time data, knew months and months ago that they would B/O Onc for mBC alone. Well guess what happened...they didn't move ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities